Allergan (Daxxify)

Daxxify is an advanced injectable treatment from Allergan, belonging to the botulinum toxin type A family. It is the first innovation of its kind in over 20 years, formulated with Peptide Exchange Technology™ to deliver longer-lasting, more stable results compared to traditional botulinum toxins.

FDA-approved for the treatment of moderate to severe glabellar lines (frown lines), Daxxify is also indicated for cervical dystonia. Its unique peptide-based formulation allows results to last up to 6–9 months—around twice as long as conventional Botox treatments—while avoiding human or animal-derived proteins, making it suitable for a wider range of patients, including vegetarians and those with certain allergies.

Key Benefits:

• Long-lasting results: up to 6–9 months of smoother skin.

• Fast onset: visible improvement often within 1–2 days.

• Innovative peptide-powered formulation for enhanced stability.

• No human or animal-derived ingredients.

Because of its extended duration, Daxxify should be administered by experienced medical professionals to ensure precise distribution and a natural, comfortable look.

Price determined by the number of units.

Price/Unit